• LANZATECH - FINANCIAL MODELLING
    LanzaTech have developed a proprietary platform for producing lowest-cost fuel ethanol. Scarlatti developed a financial model for the application of their technology to a plant using biomass (wood) as the primary feedstock. Scarlatti helped LanzaTech to secure grant funding from EECA to partially fund the work.

  • SYNTHASE BIO - FINANCIAL MODELLING
    Synthase Bio are developing and marketing a novel antioxidant enzyme for use in a variety of biological systems. Scarlatti developed a detailed financial model to assist the company’s first external fundraising and to strike an agreement with an international partner.

  • SYNTHASE BIO - MARKET SCAN
    Synthase Bio are developing and marketing a novel antioxidant enzyme for use in a variety of biological systems.  Scarlatti has undertaken a number of market scans to evaluate the potential of specific business opportunities and identify potential partners. These scans have all been undertaken quickly and on a limited budget.

  • PACIFIC EDGE - COST UTILITY ANALYSIS
    Pacific Edge develop and market a range of molecular diagnostic products for the detection of cancer. Scarlatti works with Pacific Edge to create tools that demonstrate the economic savings that Pacific Edge’s products offer for healthcare providers.